Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation
增强现实作为戒烟热线咨询的辅助手段
基本信息
- 批准号:10655290
- 负责人:
- 金额:$ 74.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAccountingAdjuvantAdoptionAnimalsAugmented RealityBehavioralBiochemicalCellular PhoneCessation of lifeCigaretteClinicClinicalComputer softwareCost AnalysisCost Effectiveness AnalysisCounselingCuesDependenceDissemination and ImplementationElementsEmerging TechnologiesEnrollmentEnvironmentEvaluationExposure toExtinctionFloridaFundingFutureGoalsGrantHourHumanHybridsIndividualInterventionInterviewLaboratoriesMental HealthMonitorMorbidity - disease rateNicotine DependenceOutcomeParticipantPatient RecruitmentsPatient Self-ReportPharmacotherapyPrediction of Response to TherapyProceduresRandomizedResearchRisk ReductionServicesSmokeSmokerSmokingSmoking Cessation InterventionSmoking StatusStimulusSubstance Use DisorderTabletsTechnologyTestingTobaccoTobacco DependenceUnited StatesUpdateWorkarmcigarette smokingconditioningcostcravingcue reactivitydesigndiariesdigitalefficacy evaluationefficacy testingexperimental studyfuture implementationimplementation questionsimprovedin vivoincremental cost-effectivenessindexinginnovationinterestmHealthmobile computingmortalitynicotine replacementnovelprimary outcomeprogramspublic health prioritiesquitlinereal world applicationrecruitremote administrationresponsesatisfactionsexsmartphone applicationsmoking abstinencesmoking cessationsmoking relapsestandard of caretext messaging interventiontherapy developmenttobacco abstinencetobacco-freetooltraittreatment armtreatment effecttreatment servicestreatment strategyuser-friendlyvirtual
项目摘要
PROJECT SUMMARY/ABSTRACT
Cigarette smoking remains the leading preventable cause of morbidity and mortality in the United States.
Developing effective cessation interventions remains a public health priority, and mHealth offers the
opportunity to reduce barriers to dissemination and implementation of cessation treatment. This project will test
the emerging technology of augmented reality (AR) to enhance smoking cessation among individuals who
contact the Tobacco Free Florida quitline for treatment services. AR inserts virtual objects into the real-world
environment as viewed on a screen (e.g., smartphone). Cue-exposure treatments have demonstrated efficacy
for decreasing tobacco craving in the laboratory, but these effects do not appear to generalize well beyond the
extinction setting. This post-extinction “renewal effect” has been demonstrated in both animal and human
studies. With the emergence of AR technology, it is now possible to conduct extinction trials across multiple
environments throughout smokers’ own real-world smoking settings. The potential to extend the effects of cue-
exposure to naturalistic settings offers the opportunity for an innovative and scalable cessation treatment that
can be administered remotely. With funding from an R34 treatment development grant, the research team has
already developed an app with the basic AR platform. Importantly, we have tested the app in controlled
experiments and found that the AR stimuli satisfied the key criterion for extinction cues in that they: (a) elicited
substantial cue-reactivity, comparable to in vivo cues and that (b) repeated exposure to the cues reduced
craving (i.e., extinction). The primary goal of the proposed project is to extend this initial work by adapting the
app for clinical use, with the objective of testing the efficacy of AR when combined with quitline treatment, while
also considering key questions relevant to future implementation. Aim 1 will expand the app to be an engaging
and user-friendly treatment tool for smokers, and to coordinate all referral procedures between the study team
and the Tobacco Free Florida quitline. Aim 2 will recruit participants from the Tobacco Free Florida quitline and
randomize individuals either to receive quitline services only or receive quitline services plus the AR app. The
primary outcome is biochemically-confirmed tobacco abstinence at 6 months post-enrollment. Aim 3 will
evaluate treatment implementation questions to guide future quitline adoption. If the AR app proves to be
efficacious, it will be ready for dissemination and implementation through quitlines as well as other smoking
cessation programs (e.g., traditional cessation counseling, text messaging interventions, other mobile
cessation apps). This work has the potential to inform a range of existing treatments not only for tobacco
dependence, but also for other substance use disorders and mental health conditions that are maintained by
principles of conditioning.
项目摘要/摘要
吸烟仍然是美国病态和死亡率的主要预防原因。
发展有效的戒烟仍然是公共卫生的先验
减少障碍物的机会和实施情况。
增强现实(AR)的新兴技术是为了增强戒烟的个人
联系烟草免费的佛罗里达戒烟线以获取治疗服务。
在屏幕上查看的象征(例如,智能手机)表现出疗效
为了减少实验室中的烟草渴望,但这种影响似乎并没有概括
灭绝设置。
随着AR技术的出现,可以进行研究。
吸烟者自己的现实吸烟环境中的环境有可能扩大提示的影响。
接触自然主义环境提供了对戒烟治疗的开放性,
可以通过R34治疗开发资助的资金来远程管理
已经开发了一个具有基本AR平台的应用程序。我们已经通过受控测试了该应用程序
经过经验并找到了灭绝线索的关键标准的AR刺激性,这是:(a)引起
实质性提示反应性,可与体内提示相当,并且(b)反复接触提示已减少
渴望(即灭绝)项目的主要目标是通过适应您
临床使用的应用程序,目的是测试与Quitline治疗结合使用AR的功效,而
还考虑与未来实施有关的关键问题。
和用户友好的吸烟工具,并协调研究团队之间的所有推荐程序
烟草免费的烟草2。
随机使个人仅接收Quitline服务,或者接收Quitline服务以及ARPP
主要结果是在注册后6个月的生化确认的烟草禁欲
评估治疗实施问题,以指导未来的Quitline采用。
有效,它将准备好通过戒烟线以及其他吸烟来传播和实施
戒烟计划(例如,传统戒烟咨询,文本消息干预,其他手机
停止应用程序)。
依赖性,也适用于其他药物使用障碍健康状况
条件原则。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine Vinci其他文献
Christine Vinci的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine Vinci', 18)}}的其他基金
Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation
增强现实作为戒烟热线咨询的辅助手段
- 批准号:
10375902 - 财政年份:2022
- 资助金额:
$ 74.39万 - 项目类别:
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
基于正念的压力管理计划对同种异体 HCT 护理人员的功效
- 批准号:
10378474 - 财政年份:2021
- 资助金额:
$ 74.39万 - 项目类别:
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
基于正念的压力管理计划对同种异体 HCT 护理人员的功效
- 批准号:
10604286 - 财政年份:2021
- 资助金额:
$ 74.39万 - 项目类别:
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
基于正念的压力管理计划对同种异体 HCT 护理人员的功效
- 批准号:
10096213 - 财政年份:2021
- 资助金额:
$ 74.39万 - 项目类别:
相似国自然基金
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
异常获利、捐赠与会计信息操纵:基于新冠疫情的准自然实验研究
- 批准号:72372061
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
相似海外基金
Prostate Specific Anti-androgen Therapy for Localized Prostate Cancer
前列腺特异性抗雄激素疗法治疗局限性前列腺癌
- 批准号:
10760194 - 财政年份:2023
- 资助金额:
$ 74.39万 - 项目类别:
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs
青蒿琥酯改善中低收入国家 HIV 阳性女性 HPV 和宫颈癌前治疗结果的可行性
- 批准号:
10762866 - 财政年份:2023
- 资助金额:
$ 74.39万 - 项目类别:
Individualized medicine to predict and prevent chemotherapy-related heart failure
预测和预防化疗相关心力衰竭的个体化药物
- 批准号:
10714111 - 财政年份:2023
- 资助金额:
$ 74.39万 - 项目类别:
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease
定义莱姆病肽聚糖诱导的病理生理学的宿主和病原体决定因素
- 批准号:
10566961 - 财政年份:2023
- 资助金额:
$ 74.39万 - 项目类别:
The Clinical History of Rectal and Urethral STIs among MSM: characterizing microbiome host immune interactions for diagnostic and vaccine advances
MSM 中直肠和尿道 STI 的临床史:表征微生物组宿主免疫相互作用以促进诊断和疫苗进展
- 批准号:
10703680 - 财政年份:2023
- 资助金额:
$ 74.39万 - 项目类别: